Öz Miraç, Gülbay Banu Eriş, Bulut Barış, Aydınlı Elif Akıncı, Kaya Aslıhan Gürün, Yıldız Öznur, Acıcan Turan, Saryal Sevgi
Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Türkiye.
PLoS One. 2025 May 21;20(5):e0324480. doi: 10.1371/journal.pone.0324480. eCollection 2025.
The aim is to develop a learning model based on clinical and survey data to assess sleep quality and identify determining factors affecting sleep quality in chronic obstructive pulmonary disease (COPD) patients.
The Pittsburgh Sleep Quality Index (PSQI) was administered to stable COPD patients to assess sleep quality. Patients were categorized into two groups: good sleep quality and poor sleep quality. Parameters for the best model were selected from a total of 61 clinical and laboratory parameters using recursive feature elimination (RFE) and the Bayesian Information Criterion (BIC). A logistic regression (LR) model was created. The model was evaluated using nested cross-validation with 5 inner and 5 outer folds, and this process was repeated with 1000 bootstrap iterations. Results were obtained with a 95% CI.
The mean age of the 132 patients was 66.68 ± 8.16 years, with a predominance of males (117, or 88.6%). Of the 132 patients, 68 were in the poor sleep quality group. In this group, the prevalence of dyspnea, snoring, witnessed apneas, and excessive daytime sleepiness (EDS) was higher. The parameters included in the model and occurrence rates in the poor sleep quality group are as follows: annual exacerbation and hospitalization (71.9%), presence of EDS (35.9%), cough (64.1%), active smoking (95.4%), short-acting beta agonist (SABA) requirement (59.4%), pH level, and coronary artery disease (CAD) (20.3%). In our final model, the test set demonstrated a sensitivity, specificity, accuracy, and AUC of 70.21%, 71.76%, 70.99%, and 0.757, respectively.
Our machine learning model, developed using clinical data of COPD patients, can predict their sleep quality. We found that high annual exacerbation and hospitalization rates, the presence of EDS and cough symptoms, active smoking, and regular use of SABA as well as high pH levels, negatively affect sleep quality. Conversely, the presence of CAD under treatment in patients positively affects sleep quality.
旨在基于临床和调查数据开发一种学习模型,以评估慢性阻塞性肺疾病(COPD)患者的睡眠质量,并确定影响睡眠质量的决定因素。
对稳定期COPD患者进行匹兹堡睡眠质量指数(PSQI)评估以评定睡眠质量。患者被分为两组:睡眠质量良好组和睡眠质量差组。使用递归特征消除(RFE)和贝叶斯信息准则(BIC)从总共61项临床和实验室参数中选择最佳模型的参数。创建了逻辑回归(LR)模型。使用5次内部折叠和5次外部折叠的嵌套交叉验证对模型进行评估,并通过1000次自助重抽样迭代重复此过程。结果以95%置信区间获得。
132例患者的平均年龄为66.68±8.16岁,男性占多数(117例,占88.6%)。在132例患者中,68例属于睡眠质量差组。在该组中,呼吸困难、打鼾、目击性呼吸暂停和日间过度嗜睡(EDS)的患病率较高。模型中包含的参数以及睡眠质量差组中的发生率如下:年度加重和住院(71.9%)、存在EDS(35.9%)、咳嗽(64.1%)、当前吸烟(95.4%)、需要使用短效β受体激动剂(SABA)(59.4%)、pH值水平以及冠状动脉疾病(CAD)(20.3%)。在我们的最终模型中,测试集的敏感性、特异性、准确性和曲线下面积(AUC)分别为70.21%、71.76%、70.99%和0.757。
我们使用COPD患者的临床数据开发的机器学习模型可以预测他们的睡眠质量。我们发现,年度加重和住院率高、存在EDS和咳嗽症状、当前吸烟、经常使用SABA以及高pH值水平对睡眠质量有负面影响。相反,接受治疗的患者中存在CAD对睡眠质量有积极影响。